The hypothesis tested was that inflammatory markers would be higher and adiponectin levels would be lower in women with a history of gestational diabetes who later developed impaired glucose tolerance (IGT) or type 2 diabetes than in women with a history of GDM who have normal glucose tolerance and that lifestyle modification would reduce inflammatory profiles. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.